miR-145-5p was previously reported to be a tumor suppressor in most types of cancers, including CRC [16, 17], and in our study, by bioinformatics analysis and experimental verification, we confirmed that CBR3-AS1 could directly bind to miR-145-5p and suppressing its expression and function in CRC. Here, CBR3 is linked to neoplasm.